Navigation Links
NIH announces new initiative in epigenomics
Date:1/24/2008

eurological Disorders and Stroke, and the National Center for Biotechnology Information of the National Library of Medicine. Efforts of these Institutes are coordinated by the Office of Portfolio Analysis and Strategic Initiatives (OPASI) as part of the NIH Roadmap.

"Epigenetic mechanisms are important in development, aging, and learning and memory, but our understanding of epigenetic processes is still very much in its infancy," said NIDA Director Nora D. Volkow. "A deeper understanding of epigenetics will enable researchers to make significant strides in understanding and treating many diseases including cancers, obesity, depression, and addiction."

Increased interest in epigenetics has spawned international research collaborations that have pushed the field forward in recent years. With the NIH Roadmap initiative, the United States will increase its commitment to epigenetics research and accelerate the pace of biomedical discovery in the next decade.

For example, epigenetics may help explain how some people are predisposed to certain illnesses such as cardiovascular disease, diabetes and hypertension. Several studies have documented that children born to mothers who did not get adequate nutrition during pregnancy were more likely to develop type 2 diabetes and coronary heart disease later in life. The theory is that epigenetic changes occur in genes that regulate sugar absorption and metabolism during fetal development that allow for survival with little food, but when encountered with an environment where food was plentiful these changes led to development of diabetes. (See scientific illustration of how epigenetic mechanisms can affect health at .)

"Although we are beginning to understand a great deal about the basic science of epigenetics, this initiative heralds its application to human health and disease. This initiative will connect real life problems with cu
'/>"/>

Contact: Karen Silver
silverk@mail.nih.gov
301-435-2435
NIH/Office of the Director
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. BD Announces Results For First Fiscal Quarter
2. Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates
3. KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM)
4. Euro RSCG Life LM&P Announces Growth of Leadership Team
5. DSS Announces Market Research Program for the Design of 2009 MA and PDP Products and Marketing Programs
6. International consortium announces the 1000 Genomes Project
7. TeamHealth Announces Eight New Clinical Outsourcing Contracts
8. Moog Inc. Announces First Quarter 2008 Earnings Webcast on January 25, 2008
9. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
10. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
11. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... WASHINGTON, Dec. 1 The... clinic in Los Angeles, has agreed to pay the Unit... received illegal kickbacks from HealthSouth Corpo... ,, The settlement resolves allegations that ...orm of stock option grants, donations to the Kerla...
(Date:12/1/2009)...ccreta is increasingly common but more easily iden...(HealthDay News) -- A magnetic resonance imaging ...tening pregnancy complication called placenta accr... when the placenta surrounding a fetus attaches to... placenta can pull out parts of the uterine wall, ...
(Date:12/1/2009)..., WASHINGTON, Dec. 1 Wi... a growing number of employers are providing self-...en enrollment season, according to a new survey by... majority of employers who offer these tools belie...an decisions. ,, According to the survey, 45 pe...
(Date:12/1/2009)..., BELLEVUE, Wash., Dec 1 Edifec...hcare Channel Modernization solutions announced an...at facilitates HIPAA 4010A1 to HIPAA 5010 migratio...0A1-5010 conversion maps, allows generation of tes...0A1 and 5010 in production, thus addressing most r...
(Date:12/1/2009)...ests that ,less affirming, isolating behaviors ju...c. 1 (HealthDay News) -- A new study suggests that...ence others to feel lonely, too. , "Loneliness ...o three degrees of separation," said James H. Fowl...er issue of the Journal of Personality and Social...
Breaking Medicine News(10 mins):Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Serious Pregnancy Complication Detected With MRI 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3
...U.S. Food and Drug Administration (FDA) today appr...m tartrate) immediate-release tablets.// Zolpidem ... indicated for the short-term treatment of insomni...nd regulatory process," said Gary J. Buehler, dire...
...chocolate giants Cadbury have to pay heavily for t...he company had failed to inform the concerned auth...traces of bacteria in the samples of chocolates at...Regulations 2004. The Birmingham City Council...
...nternational meeting organized to thrash out issue...valuable //opportunity to focus attention on a bur...al communities. Amongst the Inuit population of Nu...rowned upon for their lack of attention on child i...
...r causing bugs may not be all that bad for you. Re...Helicobacter pylori to reduced chances of developi...ew York University School of Medicine, who publish... about asthma and allergy history. This involved a...
...archers from have found that infection with HIV, t... increased risk of myocardial infarction or heart ...sk factors were also increased in study participan... a higher incidence of myocardial infarction and m...
... deficiency anemia is the commonest medical disord...fetal health.// Despite several national programme...ng pregnancy, the success has not been as anticipa...Girls born underweight are at risk of producing sm...
Other Medicine News:Health News:FDA Approves First Generic Versions of Ambien for Insomnia 2Health News:Cadbury Indicted on Salmonella Scare 2Health News:Suicide - Aboriginal Communities Take Stock of the Killing Numbers 2Health News:Ulcer Causing Microbe Linked To Protection From Asthma 2Health News:HIV Infection Associated With Increased Risk of Heart Attack 2
(Date:12/1/2009)... , , LANSING, Mich., Dec. 1 /PRNewswire-Fi...nounced today that it has acquired the BioKits foo...robe Incorporated ( GPRO). The acquisition include...and fish speciation, and plant genetics. ,, Gen...cquisition of Tepnel Life Sciences plc in April 20...
(Date:12/1/2009)... , , ARLINGTON, Va., Dec. 1 /PRNewswi...f its newest report, The Market Outlook for Rese... appropriated to the NIH Scientific Research progr...ARRA) is being earmarked for lab renovations, Chal...nd research that spans multiple public and non-pro...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire-First...leading source of health information, today announ...wards. The fourth annual WebMD Health Heroes honor...courage and perseverance, who lead an effort to he... http://www.newscom.com/cgi-bin/prnh/20091201/NY...
Breaking Medicine Technology:Neogen Acquires Gen-Probe's BioKits Food Safety Business 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3Aprima and MRM Partner to Bring Award Winning Electronic Health Record Solution to Practices in Tennessee Virginia 59337 1Aprima and MRM Partner to Bring Award Winning Electronic Health Record Solution to Practices in Tennessee Virginia 59337 2Aprima and MRM Partner to Bring Award Winning Electronic Health Record Solution to Practices in Tennessee Virginia 59337 3Humidifiers Not Just for Children Anymore AchooAllergy com Announces All New Humidifiers Offering 59335 1Humidifiers Not Just for Children Anymore AchooAllergy com Announces All New Humidifiers Offering 59335 2Humidifiers Not Just for Children Anymore AchooAllergy com Announces All New Humidifiers Offering 59335 3ADSC 26apos 3Bs Pain Management Reinforcement 59333 1ADSC 26apos 3Bs Pain Management Reinforcement 59333 2
...ifornia, June 4 BN,ImmunoTherapeutics, Inc. has i...apeutic vaccine candidate against prostate cancer....8 male patients with,non-metastatic as well as hor...nt in the US. Secondary objectives of the trial in...ce prostate antigen-specific immune,responses, as ...
... of the Dana-Farber Cancer Institute presents phas...al activity of perifosine in patients with relap...NEW YORK, June 3 Keryx Biopharmaceuticals,Inc. (N...s of perifosine,(KRX-0401) in patients with relaps...was presented at the 44th Annual Meeting of the,Am...
Other Medicine Technology:BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine 2Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 2Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 3Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 4Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 5Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology 6
COCOONReusableLower Torso
Model 522 - Upper Body Blanket
CritiCool™
...he OPMI VISU 210, Carl Zeiss has created a surgica...e state-of-the-art for ophthalmic surgery. Its wid...urgeons and it offers new functions to improve dep...pletely integrated assistant's microscope the OPMI...
Medicine Products: